Skip to main content
Premium Trial:

Request an Annual Quote

Zygem, Advalytix Partner on DNA Extraction Products

NEW YORK (GenomeWeb News) – Zygem said today that it has signed an agreement with Advalytix, a unit of Olympus Life Science Research Europe, to develop and sell a private-label line of DNA extraction products.
 
The partnership will combine Zygem’s enzymatic nucleic acid extraction technology with Advalytix’s expertise in single-cell molecular tests for life science research and diagnostic applications. Advalytix will market the DNA extraction products, which are designed to work with Advalytix’s single-cell molecular diagnostics and miniaturized diagnostic and biological tests for research and development.
 
Zygem’s technology uses a thermophilic enzyme to extract DNA from samples using a single closed-tube system. The Solana Beach, Calif.-based firm said that the technology has been validated for use in research, forensic, diagnostic, agriculture, and animal health applications.
 
Terms of the alliance were not disclosed.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.